June F Maia

The benefits of soluble non-bacterial fraction of kefir on blood pressure and cardiac hypertrophy in hypertensive rats are mediated by an increase in baroreflex sensitivity and decrease in angiotensin-converting enzyme activity.

D. Lenz, T. U. de Andrade, D. Endringer, 2018, Nutrition.

Induction of NAD (P)H: Quinone reductase 1 (QR1) and antioxidant activities in vitro of ‘Toranja Burarama’ (Citrus maxima [Burm.] Merr.)

J. Pezzuto, D. Lenz, D. Endringer, 2018, Phytotherapy research : PTR.

Kefir improves blood parameters and reduces cardiovascular risks in patients with metabolic syndrome

D. Lenz, D. Endringer, N. Bissoli, 2021 .

Chronic and acute effects of kefir: the role of angiotensin converting enzyme inhibition instead of nitric oxide balance

E. Lima, G. Brasil, T. Andrade, 2021, Brazilian Journal of Pharmaceutical Sciences.